Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate, Ibandronate, and Risedronate for Postmenopausal Osteoporosis
NCT00666627Phase 2Completed
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Apr 2007
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of alendronate, ibandronate and risedronate in postmenopausal osteoporosis, sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Started Apr 2007; status: completed.
02
Drugs
alendronateibandronaterisedronate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00666627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00666627.